SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-23-183814
Filing Date
2023-07-07
Accepted
2023-07-07 16:21:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D d527676dsc13d.htm SC 13D 56022
  Complete submission text file 0001193125-23-183814.txt   57546
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filed by) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations

Mailing Address AESCHENVORSTADT 36 BASEL V8 4051
Business Address AESCHENVORSTADT 36 BASEL V8 4051 41 61 551 30 30
VectivBio Holding AG (Subject) CIK: 0001836379 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92481 | Film No.: 231077024
SIC: 2836 Biological Products, (No Diagnostic Substances)